| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hirofumi Hirakawa, Takeshi Terao, Masaaki Muronag. Successful treatment using combined monthly maintenance electroconvulsive therapy and monthly long-acting injection paliperidone for treatment-resistant schizophrenia with vulnerability to clozapine: a case report. Psychiatry and clinical neurosciences. 2022-07-13. PMID:35822460. |
successful treatment using combined monthly maintenance electroconvulsive therapy and monthly long-acting injection paliperidone for treatment-resistant schizophrenia with vulnerability to clozapine: a case report. |
2022-07-13 |
2023-08-14 |
Not clear |
| Georgios Schoretsanitis, Jose de Leo. Best Practices for Starting Clozapine in Patients With Schizophrenia: How to Switch From the Prior Antipsychotic(s). The Journal of clinical psychiatry. vol 83. issue 4. 2022-07-08. PMID:35802932. |
best practices for starting clozapine in patients with schizophrenia: how to switch from the prior antipsychotic(s). |
2022-07-08 |
2023-08-14 |
Not clear |
| Amarpreet Singh, Darci Delgado, Maria I Ventura, Eric Schwartz, Jared Williams, Jonathan M Meye. Clozapine Use and Forensic Outcomes in Psychiatric Inpatients Deemed Incompetent to Stand Trial. The journal of the American Academy of Psychiatry and the Law. 2022-07-07. PMID:35798392. |
there were 191 new clozapine starts among ist patients, 92.7 percent of whom were diagnosed with schizophrenia or another psychosis. |
2022-07-07 |
2023-08-14 |
Not clear |
| Evyn Peters, Arash Shamloo, Rohit J Lodhi, Gene Marcoux, Kylie Jackson, Shawn Halayka, Lloyd Balbuen. Medication Gaps and Antipsychotic Polypharmacy in Previously Hospitalized Schizophrenia Patients: An Electronic Cohort Study in Three Canadian Provinces. Frontiers in psychiatry. vol 13. 2022-07-05. PMID:35782434. |
we aimed to calculate the cumulative time spent in second generation antipsychotics (sgas), gaps, antipsychotic polypharmacy, and clozapine in discharged schizophrenia patients. |
2022-07-05 |
2023-08-14 |
Not clear |
| Anita Margarette Bayya Ventura, Richard D Hayes, Daniela Fonseca de Freita. Ethnic disparities in clozapine prescription for service-users with schizophrenia-spectrum disorders: a systematic review. Psychological medicine. 2022-07-05. PMID:35787301. |
clozapine is the only licenced medication for treating treatment-resistant schizophrenia. |
2022-07-05 |
2023-08-14 |
Not clear |
| Anita Margarette Bayya Ventura, Richard D Hayes, Daniela Fonseca de Freita. Ethnic disparities in clozapine prescription for service-users with schizophrenia-spectrum disorders: a systematic review. Psychological medicine. 2022-07-05. PMID:35787301. |
we searched cinahl, pubmed, medline, embase, apa psycinfo and open grey and reviewed studies reporting on the proportion of service-users prescribed clozapine separately for different ethnic groups, in individuals with a primary diagnosis of schizophrenia or any schizophrenia-spectrum disorders. |
2022-07-05 |
2023-08-14 |
Not clear |
| Sandeep Grover, Chandrima Naskar, Subho Chakrabart. Factors Associated With Poor Response to Clozapine in Schizophrenia: A Study From Northern India. Journal of clinical psychopharmacology. vol 42. issue 4. 2022-06-28. PMID:35763756. |
factors associated with poor response to clozapine in schizophrenia: a study from northern india. |
2022-06-28 |
2023-08-14 |
Not clear |
| Sandeep Grover, Chandrima Naskar, Subho Chakrabart. Factors Associated With Poor Response to Clozapine in Schizophrenia: A Study From Northern India. Journal of clinical psychopharmacology. vol 42. issue 4. 2022-06-28. PMID:35763756. |
this study aimed to assess the demographic and clinical factors associated with an inadequate response to clozapine in patients with treatment-resistant schizophrenia (trs). |
2022-06-28 |
2023-08-14 |
Not clear |
| Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, Mirko Manchia, Vincenzo De Luca, Felice Iasevoli, Christoph U Correl. Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia. Pharmacology & therapeutics. 2022-06-28. PMID:35764175. |
almost fifty years after its first introduction into clinical care, clozapine remains the only evidence-based pharmacological option for treatment-resistant schizophrenia (trs), which affects approximately 30% of patients with schizophrenia. |
2022-06-28 |
2023-08-14 |
Not clear |
| C U Correll, Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Niko Seppälä, Oliver D Howe. A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia. CNS drugs. 2022-06-27. PMID:35759211. |
a guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia. |
2022-06-27 |
2023-08-14 |
Not clear |
| Yue Feng Quek, Yuen Mei See, Jie Yin Yee, Gurpreet Rekhi, Boon Tat Ng, Charmaine Tang, Jimmy Le. Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia. Asian journal of psychiatry. vol 74. 2022-06-25. PMID:35751958. |
metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia. |
2022-06-25 |
2023-08-14 |
Not clear |
| Yue Feng Quek, Yuen Mei See, Jie Yin Yee, Gurpreet Rekhi, Boon Tat Ng, Charmaine Tang, Jimmy Le. Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia. Asian journal of psychiatry. vol 74. 2022-06-25. PMID:35751958. |
thus, this study aims to establish and compare the cardiometabolic profiles between non-clozapine antipsychotic and clozapine users with schizophrenia. |
2022-06-25 |
2023-08-14 |
Not clear |
| Hong Seok Oh, Bong Ju Lee, Yu Sang Lee, Ok-Jin Jang, Yukako Nakagami, Toshiya Inada, Takahiro A Kato, Shigenobu Kanba, Mian-Yoon Chong, Sih-Ku Lin, Tianmei Si, Yu-Tao Xiang, Ajit Avasthi, Sandeep Grover, Roy Abraham Kallivayalil, Pornjira Pariwatcharakul, Kok Yoon Chee, Andi J Tanra, Golam Rabbani, Afzal Javed, Samudra Kathiarachchi, Win Aung Myint, Tran Van Cuong, Yuxi Wang, Kang Sim, Norman Sartorius, Chay-Hoon Tan, Naotaka Shinfuku, Yong Chon Park, Seon-Cheol Par. Machine Learning Algorithm-Based Prediction Model for the Augmented Use of Clozapine with Electroconvulsive Therapy in Patients with Schizophrenia. Journal of personalized medicine. vol 12. issue 6. 2022-06-24. PMID:35743753. |
machine learning algorithm-based prediction model for the augmented use of clozapine with electroconvulsive therapy in patients with schizophrenia. |
2022-06-24 |
2023-08-14 |
Not clear |
| Hong Seok Oh, Bong Ju Lee, Yu Sang Lee, Ok-Jin Jang, Yukako Nakagami, Toshiya Inada, Takahiro A Kato, Shigenobu Kanba, Mian-Yoon Chong, Sih-Ku Lin, Tianmei Si, Yu-Tao Xiang, Ajit Avasthi, Sandeep Grover, Roy Abraham Kallivayalil, Pornjira Pariwatcharakul, Kok Yoon Chee, Andi J Tanra, Golam Rabbani, Afzal Javed, Samudra Kathiarachchi, Win Aung Myint, Tran Van Cuong, Yuxi Wang, Kang Sim, Norman Sartorius, Chay-Hoon Tan, Naotaka Shinfuku, Yong Chon Park, Seon-Cheol Par. Machine Learning Algorithm-Based Prediction Model for the Augmented Use of Clozapine with Electroconvulsive Therapy in Patients with Schizophrenia. Journal of personalized medicine. vol 12. issue 6. 2022-06-24. PMID:35743753. |
the augmentation of clozapine with electroconvulsive therapy (ect) has been an optimal treatment option for patients with treatment- or clozapine-resistant schizophrenia. |
2022-06-24 |
2023-08-14 |
Not clear |
| Hong Seok Oh, Bong Ju Lee, Yu Sang Lee, Ok-Jin Jang, Yukako Nakagami, Toshiya Inada, Takahiro A Kato, Shigenobu Kanba, Mian-Yoon Chong, Sih-Ku Lin, Tianmei Si, Yu-Tao Xiang, Ajit Avasthi, Sandeep Grover, Roy Abraham Kallivayalil, Pornjira Pariwatcharakul, Kok Yoon Chee, Andi J Tanra, Golam Rabbani, Afzal Javed, Samudra Kathiarachchi, Win Aung Myint, Tran Van Cuong, Yuxi Wang, Kang Sim, Norman Sartorius, Chay-Hoon Tan, Naotaka Shinfuku, Yong Chon Park, Seon-Cheol Par. Machine Learning Algorithm-Based Prediction Model for the Augmented Use of Clozapine with Electroconvulsive Therapy in Patients with Schizophrenia. Journal of personalized medicine. vol 12. issue 6. 2022-06-24. PMID:35743753. |
using data from the research on asian psychotropic prescription patterns for antipsychotics survey, which was the largest international psychiatry research collaboration in asia, our study aimed to develop a machine learning algorithm-based substantial prediction model for the augmented use of clozapine with ect in patients with schizophrenia in terms of precision medicine. |
2022-06-24 |
2023-08-14 |
Not clear |
| Hong Seok Oh, Bong Ju Lee, Yu Sang Lee, Ok-Jin Jang, Yukako Nakagami, Toshiya Inada, Takahiro A Kato, Shigenobu Kanba, Mian-Yoon Chong, Sih-Ku Lin, Tianmei Si, Yu-Tao Xiang, Ajit Avasthi, Sandeep Grover, Roy Abraham Kallivayalil, Pornjira Pariwatcharakul, Kok Yoon Chee, Andi J Tanra, Golam Rabbani, Afzal Javed, Samudra Kathiarachchi, Win Aung Myint, Tran Van Cuong, Yuxi Wang, Kang Sim, Norman Sartorius, Chay-Hoon Tan, Naotaka Shinfuku, Yong Chon Park, Seon-Cheol Par. Machine Learning Algorithm-Based Prediction Model for the Augmented Use of Clozapine with Electroconvulsive Therapy in Patients with Schizophrenia. Journal of personalized medicine. vol 12. issue 6. 2022-06-24. PMID:35743753. |
using the machine learning algorithm, our findings allow the development of a substantial prediction model for the augmented use of clozapine with ect in asian patients with schizophrenia. |
2022-06-24 |
2023-08-14 |
Not clear |
| Hong Seok Oh, Bong Ju Lee, Yu Sang Lee, Ok-Jin Jang, Yukako Nakagami, Toshiya Inada, Takahiro A Kato, Shigenobu Kanba, Mian-Yoon Chong, Sih-Ku Lin, Tianmei Si, Yu-Tao Xiang, Ajit Avasthi, Sandeep Grover, Roy Abraham Kallivayalil, Pornjira Pariwatcharakul, Kok Yoon Chee, Andi J Tanra, Golam Rabbani, Afzal Javed, Samudra Kathiarachchi, Win Aung Myint, Tran Van Cuong, Yuxi Wang, Kang Sim, Norman Sartorius, Chay-Hoon Tan, Naotaka Shinfuku, Yong Chon Park, Seon-Cheol Par. Machine Learning Algorithm-Based Prediction Model for the Augmented Use of Clozapine with Electroconvulsive Therapy in Patients with Schizophrenia. Journal of personalized medicine. vol 12. issue 6. 2022-06-24. PMID:35743753. |
this substantial prediction model can support further studies to develop a substantial prediction model for the augmented use of clozapine with ect in patients with schizophrenia in a strict epidemiological context. |
2022-06-24 |
2023-08-14 |
Not clear |
| Silvia Moga, Andreea Teodorescu, Ana Dragan, Ana Aliana Miron, Petru Iften. Neutropenia in Patients With Clozapine-Treated Schizophrenia: An Effect of Clozapine or a Consequence of SARS-CoV-2 Infection? A Systematic Review. American journal of therapeutics. 2022-06-24. PMID:35749754. |
neutropenia in patients with clozapine-treated schizophrenia: an effect of clozapine or a consequence of sars-cov-2 infection? |
2022-06-24 |
2023-08-14 |
Not clear |
| Silvia Moga, Andreea Teodorescu, Ana Dragan, Ana Aliana Miron, Petru Iften. Neutropenia in Patients With Clozapine-Treated Schizophrenia: An Effect of Clozapine or a Consequence of SARS-CoV-2 Infection? A Systematic Review. American journal of therapeutics. 2022-06-24. PMID:35749754. |
clozapine is the only approved antipsychotic for treatment-resistant schizophrenia. |
2022-06-24 |
2023-08-14 |
Not clear |
| Camilla Marasca, Roberto Mandrioli, Roccaldo Sardella, Tomaž Vovk, Andrea Armirotti, Andrea Cavalli, Alessandro Serretti, Michele Protti, Laura Mercolin. Dried Volumetric Microsampling Approaches for the Therapeutic Drug Monitoring of Psychiatric Patients Undergoing Clozapine Treatment. Frontiers in psychiatry. vol 13. 2022-06-20. PMID:35722565. |
clozapine is one of the most widely used second-generation antipsychotic drugs (sgas) for the treatment of schizophrenia. |
2022-06-20 |
2023-08-14 |
Not clear |